Physician profile
Patrick J Russo
NPI 1861490195
$1,662.89
in general payments reported to CMS, 2019-2025
11 companies · $913 in 2025
The $913 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2021: $124 · 2022: $168 · 2023: $163 · 2024: $184 · 2025: $913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $389.91 | 2019-2025 | Aveir, Amplatzer Talisman, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $367.15 | 2021-2025 | Avvigo Guidance System, Watchman Flx, Watchman Access System |
| Abiomed | $211.51 | 2025 | |
| Heartflow, INC. | $192.58 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $102.09 | 2024 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.60 | 2025 | Jardiance |
| W. L. Gore & Associates, INC. | $91.53 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.64 | 2023-2025 | Lifevest |
| Masimo Corporation | $42.18 | 2025 | Sedline |
| Kestra Medical Technology Services, INC. | $38.46 | 2025 | Assure Wcd |
| Ge Healthcare | $37.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.